The study, which combined the use of HBOT in the treatment of animals genetically engineered to develop Alzheimer’s and a group of individuals over the age of 65 who were already having memory loss.
Study results show elevated blood flow and improved oxygenation in the brain of patients suffering from cognitive impairment(photo credit: Aging/Uri Ashery)ByMAAYAN JAFFE-HOFFMAN
